Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Monsanto Company (MON): Why This Stock Won’t Pause Even if Markets Slip

Not too long ago, I tagged this stock as one of the best picks for 2013 riding on stupendous numbers, solid guidance, and macro tailwinds. Two days back, it hit a 52-week high, taking its year-to-date returns up to nearly 8%.

Monsanto Company (NYSE:MON)

What is Monsanto Company (NYSE:MON)’s USP? Has it really fared well enough to deserve these premium valuations? More importantly, is it time to book some profits, hold on, or even dive into the stock right now?

Outstanding work

If a stock touches a 52-week high, it is only prudent to see how the company has performed over the past year, particularly in terms of top and bottom line growth. Monsanto has pulled it off quite well.

MON Revenue TTM data by YCharts

These figures look brilliant. I particularly like the fact that Monsanto Company (NYSE:MON)’s net income has grown at a pace more than twice that of revenue. I give a green thumbs up to a company that can convert its incremental revenue into income with such proficiency, because that only reflects management’s cost-control capabilities even as the company grows.

Reaping the fruits

So does it also mean that Monsanto outsmarted its peers in the game? Here’s how it stacks up against the two closest rivals in the seed business.

Company Revenue growth % Gross Profit Margin % Net Profit Margin % Debt-to-Equity % Return On Equity
Monsanto 12.6 52.5 16.1 17 19.4
(2.3) 27.5 7.9 117 30
Syngenta (NYSE:SYT) 6.8 49.2 13.2 41 23

Trailing Twelve Month figures

Monsanto Company (NYSE:MON) is the prettiest picture out there, beating DuPont and Syngenta across all measures. The best part is that Monsanto also sports the lowest total debt-to-equity ratio among the three, which somehow also explains its lower ROE. Higher leverage almost always pushes up ROE. Monsanto tops off with an enviable free cash flow of nearly $2.9 billion. That makes it one of the few companies that churn out greater cash than it earns as profits.

Monsanto is one of the best plays in the agriculture sector for two reasons – one, it deals in a product that is better insulated compared to other agriculture items, and two, it enjoys a leadership position in its field.

Top-class business

Seeds are indispensable needs for farmers, irrespective of the weather conditions. One might want to put fertilizers in the same league, but the problem with the fertilizer industry is that it is highly prone to fluctuations in prices, unlike seeds. Take the case of Potash (NYSE:POT)Corp, which dominates the potash nutrient market in the U.S. Like Monsanto Company (NYSE:MON), it faced the ups and downs of a solid spring followed by the most severe drought ever last year. But while Monsanto crossed over comfortably, PotashCorp ended 2012 with 9% drop in revenue and a dismal 32% slump in profits. Blame lower nutrient prices and soft global demand for potash. Comparatively, CF Industries, the nitrogen king, had a much stronger 2012. Nitrogen enjoys better demand as well as prices compared to as one of the most essential nutrients. Simply put, the volatility in fertilizer business is evident.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.